CRB’s Stuttgart office relocates to a larger space in Böblingen
Nov 21, 2022
CRB has relocated its Stuttgart operations to a larger space in the historic city of Böblingen, a center of technology and industry.
Joining recently expanded operations in Basel, Switzerland, the new Stuttgart-area facility positions CRB for continued rapid client and employee growth and underscores its commitment to building AEC market leadership across the European Union. The Böblingen space enables CRB to expand its professional staff by up to 50% as it continues serving Europe’s life sciences, biotech, and emerging markets. Recently, the company was ranked #44 in the Top 50 Design Firms in International Markets by Engineering News-Record.
The new office in Böblingen features a variety of meeting spaces named for regional areas and designed with artwork reflecting the region’s extraordinary scenery, architecture, and landmark structures. CRB’s new space includes a training facility, on-site cafeteria, and community and private break rooms. The office is easily accessible to mass-transit options and the city’s wealth of historic and cultural attractions.
The company also recently completed relocation of its Basel operations to a new office that expands accommodations for employees and clients, in a city that has become a global hub for the pharmaceutical industry. CRB’s space is a short walk from Basel’s historic old town and includes ample client meeting space and an office layout designed to maximize collaboration and the employee experience.
“We have achieved tremendous success in a short period of time in Europe, and these new spaces represent our rising commitment to providing the resources of a global firm locally to clients who drive innovation in pharmaceutical health care and speed therapies to patients,” said Eric Unrau, CRB’s Vice President of European Operations. “From the site selection and interior design to the use of technology, we prioritized creating a work environment that connects with our core values, supports our employees and aligns with our clients’ needs. We are delighted to start the next phase of our growth in this important region.”
Since opening its European operations in 2016 with two employees, CRB’s workforce on the continent has grown to nearly 100 professionals who support some of the most essential life sciences work with engineering, procurement and construction management for global leaders including Pfizer, BioNTech, and Takeda. The company’s project teams have delivered for clients developing and delivering commercial-scale COVID-19 mRNA vaccines and facilities for oral solid dosage drugs and aseptic filling.